A Look at the CER Communications Landscape
The digital landscape has opened the door for a variety of stakeholders to share comparative effectiveness research (CER) online, but it’s not always easy to gauge the quality of the information. Although the pharmaceutical industry’s data and communications are subject to strict standards, there is no formal oversight of CER communications shared by other stakeholders. Dr. Steven Romano, Pfizer senior vice president, head, Medicines, describes the impact that the varying standards have on information-sharing in this video.
The digital landscape has opened the door for a variety of stakeholders to share comparative effectiveness research (CER) online, but it’s not always easy to gauge the quality of the information. Although the pharmaceutical industry’s data and communications are subject to strict standards, there is no formal oversight of CER communications shared by other stakeholders. Dr. Steven Romano, Pfizer senior vice president, head, Medicines, describes the impact that the varying standards have on information-sharing in this video.
[[{"fid":"743","view_mode":"teaser","type":"media","attributes":{"height":"390","width":"640","border":"0","alt":"Pfizer's Romano on Industry's Abililty to Communicate CER Findings","class":"panopoly-image-video media-element file-teaser"}}]]
The uneven CER communications landscape will be the focus of a Health Affairs briefing at the Washington Marriott at Metro Center on Thursday, October 11, 8:30 a.m. – 12:30 p.m. Register now!